Drugs / Calcium Formate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00204893 | Jul 2003 → Mar 2007 | — | University of Wisconsin, Madison | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06417476 Background | Dec 2022 → Sep 2025 overdue | rectal neoplasm | Pei-Rong Ding | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Calcium Formate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06417476 ↗ |
| Route | Oral | “12 healthy women ingested calcium formate (1,300 mg) three times a day for 14 days.” PMID 19456257 ↗ Jun 2009 |